The Promises and Pitfalls of CRISPR-Mediated Base Editing in Stem Cells.

IF 3.7 4区 生物学 Q2 GENETICS & HEREDITY
Poh Kuan Wong, Nurul Nadia Mohamad Zamberi, Saiful Effendi Syafruddin, Fook Choe Cheah, Norazrina Azmi, Jia Xian Law, Eng Wee Chua
{"title":"The Promises and Pitfalls of CRISPR-Mediated Base Editing in Stem Cells.","authors":"Poh Kuan Wong,&nbsp;Nurul Nadia Mohamad Zamberi,&nbsp;Saiful Effendi Syafruddin,&nbsp;Fook Choe Cheah,&nbsp;Norazrina Azmi,&nbsp;Jia Xian Law,&nbsp;Eng Wee Chua","doi":"10.1089/crispr.2023.0013","DOIUrl":null,"url":null,"abstract":"<p><p>Stem cells such as induced pluripotent stem cells, embryonic stem cells, and hematopoietic stem and progenitor cells are growing in importance in disease modeling and regenerative medicine. The applications of CRISPR-based gene editing to create a mélange of disease and nondisease stem cell lines have further enhanced the utility of this innately versatile group of cells in the studies of human genetic disorders. Precise base edits can be achieved using a variety of CRISPR-centric approaches, particularly homology-directed repair and the recently developed base editors and prime editors. Despite its much-touted potential, editing single DNA bases is technically challenging. In this review, we discuss the strategies for achieving exact base edits in the creation of various stem cell-based models for use in elucidating disease mechanisms and assessing drug efficacy, and the unique characteristics of stem cells that warrant special considerations.</p>","PeriodicalId":54232,"journal":{"name":"CRISPR Journal","volume":"6 3","pages":"196-215"},"PeriodicalIF":3.7000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CRISPR Journal","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/crispr.2023.0013","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 1

Abstract

Stem cells such as induced pluripotent stem cells, embryonic stem cells, and hematopoietic stem and progenitor cells are growing in importance in disease modeling and regenerative medicine. The applications of CRISPR-based gene editing to create a mélange of disease and nondisease stem cell lines have further enhanced the utility of this innately versatile group of cells in the studies of human genetic disorders. Precise base edits can be achieved using a variety of CRISPR-centric approaches, particularly homology-directed repair and the recently developed base editors and prime editors. Despite its much-touted potential, editing single DNA bases is technically challenging. In this review, we discuss the strategies for achieving exact base edits in the creation of various stem cell-based models for use in elucidating disease mechanisms and assessing drug efficacy, and the unique characteristics of stem cells that warrant special considerations.

干细胞中crispr介导的碱基编辑的希望和缺陷。
干细胞,如诱导多能干细胞、胚胎干细胞、造血干细胞和祖细胞,在疾病建模和再生医学中越来越重要。基于crispr的基因编辑应用于创建一系列疾病和非疾病干细胞系,进一步增强了这一天生多用途的细胞群在人类遗传疾病研究中的效用。精确的碱基编辑可以使用各种以crispr为中心的方法来实现,特别是同源定向修复和最近开发的碱基编辑器和引物编辑器。尽管它的潜力被大肆吹捧,但编辑单个DNA碱基在技术上具有挑战性。在这篇综述中,我们讨论了在创建各种基于干细胞的模型中实现精确碱基编辑的策略,这些模型用于阐明疾病机制和评估药物疗效,以及需要特别考虑的干细胞的独特特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CRISPR Journal
CRISPR Journal Biochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
6.30
自引率
2.70%
发文量
76
期刊介绍: In recognition of this extraordinary scientific and technological era, Mary Ann Liebert, Inc., publishers recently announced the creation of The CRISPR Journal -- an international, multidisciplinary peer-reviewed journal publishing outstanding research on the myriad applications and underlying technology of CRISPR. Debuting in 2018, The CRISPR Journal will be published online and in print with flexible open access options, providing a high-profile venue for groundbreaking research, as well as lively and provocative commentary, analysis, and debate. The CRISPR Journal adds an exciting and dynamic component to the Mary Ann Liebert, Inc. portfolio, which includes GEN (Genetic Engineering & Biotechnology News) and more than 80 leading peer-reviewed journals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信